AU2003281745B2 - Insect repellant - Google Patents
Insect repellant Download PDFInfo
- Publication number
- AU2003281745B2 AU2003281745B2 AU2003281745A AU2003281745A AU2003281745B2 AU 2003281745 B2 AU2003281745 B2 AU 2003281745B2 AU 2003281745 A AU2003281745 A AU 2003281745A AU 2003281745 A AU2003281745 A AU 2003281745A AU 2003281745 B2 AU2003281745 B2 AU 2003281745B2
- Authority
- AU
- Australia
- Prior art keywords
- copolymer
- oil
- composition according
- pvp
- insect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000077 insect repellent Substances 0.000 title claims description 28
- 235000019198 oils Nutrition 0.000 claims description 90
- 239000003921 oil Substances 0.000 claims description 88
- 239000000203 mixture Substances 0.000 claims description 82
- 229920001577 copolymer Polymers 0.000 claims description 71
- 239000000341 volatile oil Substances 0.000 claims description 52
- 241000255925 Diptera Species 0.000 claims description 41
- 241000378467 Melaleuca Species 0.000 claims description 38
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 claims description 38
- 229960001673 diethyltoluamide Drugs 0.000 claims description 34
- 244000281995 Backhousia citriodora Species 0.000 claims description 33
- 235000009465 Backhousia citriodora Nutrition 0.000 claims description 33
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 32
- 241000238631 Hexapoda Species 0.000 claims description 28
- 239000007921 spray Substances 0.000 claims description 24
- 239000006071 cream Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 13
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 claims description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- 241000545744 Hirudinea Species 0.000 claims description 10
- 229940048053 acrylate Drugs 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 229940008099 dimethicone Drugs 0.000 claims description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 10
- -1 methylacryloyl ethyl Chemical group 0.000 claims description 9
- 230000001846 repelling effect Effects 0.000 claims description 9
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 8
- VYZKQGGPNIFCLD-UHFFFAOYSA-N 3,3-dimethylhexane-2,2-diol Chemical compound CCCC(C)(C)C(C)(O)O VYZKQGGPNIFCLD-UHFFFAOYSA-N 0.000 claims description 7
- 241000258242 Siphonaptera Species 0.000 claims description 7
- 235000011037 adipic acid Nutrition 0.000 claims description 7
- 239000001361 adipic acid Substances 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 239000000516 sunscreening agent Substances 0.000 claims description 7
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 6
- 241000238876 Acari Species 0.000 claims description 6
- 235000013871 bee wax Nutrition 0.000 claims description 6
- 239000012166 beeswax Substances 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- 239000008168 almond oil Substances 0.000 claims description 5
- 229920006037 cross link polymer Polymers 0.000 claims description 5
- 229930195733 hydrocarbon Natural products 0.000 claims description 5
- 150000002430 hydrocarbons Chemical class 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
- 239000005977 Ethylene Substances 0.000 claims description 4
- 241001264681 Melaleuca linariifolia Species 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 4
- 230000004888 barrier function Effects 0.000 claims description 4
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 230000000052 comparative effect Effects 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- WMZHDICSCDKPFS-UHFFFAOYSA-N triacont-1-ene Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC=C WMZHDICSCDKPFS-UHFFFAOYSA-N 0.000 claims description 4
- 244000144725 Amygdalus communis Species 0.000 claims description 3
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 3
- 241000255129 Phlebotominae Species 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- YHHHHJCAVQSFMJ-FNORWQNLSA-N (3e)-deca-1,3-diene Chemical compound CCCCCC\C=C\C=C YHHHHJCAVQSFMJ-FNORWQNLSA-N 0.000 claims description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 2
- QJJDJWUCRAPCOL-UHFFFAOYSA-N 1-ethenoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOC=C QJJDJWUCRAPCOL-UHFFFAOYSA-N 0.000 claims description 2
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 claims description 2
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 claims description 2
- 241000256118 Aedes aegypti Species 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 239000004716 Ethylene/acrylic acid copolymer Substances 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000020 Nitrocellulose Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical class C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- JBSLOWBPDRZSMB-FPLPWBNLSA-N dibutyl (z)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C/C(=O)OCCCC JBSLOWBPDRZSMB-FPLPWBNLSA-N 0.000 claims description 2
- YFCVAZGXPLMNDG-UHFFFAOYSA-N dimethyl-bis[[methyl(diphenyl)silyl]oxy]silane Chemical compound C=1C=CC=CC=1[Si](C)(C=1C=CC=CC=1)O[Si](C)(C)O[Si](C)(C=1C=CC=CC=1)C1=CC=CC=C1 YFCVAZGXPLMNDG-UHFFFAOYSA-N 0.000 claims description 2
- ANXXYABAFAQBOT-UHFFFAOYSA-N dodecyl-methyl-bis(trimethylsilyloxy)silane Chemical compound CCCCCCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C ANXXYABAFAQBOT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 229920006227 ethylene-grafted-maleic anhydride Polymers 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 2
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 claims description 2
- PHLASVAENYNAOW-UHFFFAOYSA-N methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C=1C=CC=CC=1)O[Si](C=1C=CC=CC=1)(C)O[Si](C)(C=1C=CC=CC=1)C1=CC=CC=C1 PHLASVAENYNAOW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004200 microcrystalline wax Substances 0.000 claims description 2
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 2
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- 229920001220 nitrocellulos Polymers 0.000 claims description 2
- 229940088590 perfluoropolymethylisopropyl ether Drugs 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920001522 polyglycol ester Polymers 0.000 claims description 2
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229940047670 sodium acrylate Drugs 0.000 claims description 2
- 229920003048 styrene butadiene rubber Polymers 0.000 claims description 2
- 229940117985 trimethyl pentaphenyl trisiloxane Drugs 0.000 claims description 2
- GVPDNFYOFKBFEN-UHFFFAOYSA-N trimethyl(octadecoxy)silane Chemical compound CCCCCCCCCCCCCCCCCCO[Si](C)(C)C GVPDNFYOFKBFEN-UHFFFAOYSA-N 0.000 claims description 2
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 claims description 2
- QCZAWDGAVJMPTA-RNFRBKRXSA-N ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C Chemical compound ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C QCZAWDGAVJMPTA-RNFRBKRXSA-N 0.000 claims 2
- 239000003086 colorant Substances 0.000 claims 1
- GWDILONWJXSNDD-UHFFFAOYSA-N docosanoic acid;n'-propylethane-1,2-diamine Chemical compound CCCNCCN.CCCCCCCCCCCCCCCCCCCCCC(O)=O GWDILONWJXSNDD-UHFFFAOYSA-N 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 description 44
- 230000002940 repellent Effects 0.000 description 43
- 239000005871 repellent Substances 0.000 description 43
- 238000009472 formulation Methods 0.000 description 27
- 239000000047 product Substances 0.000 description 21
- 239000000839 emulsion Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 241001124166 Musca vetustissima Species 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 5
- 229940031578 diisopropyl adipate Drugs 0.000 description 5
- 210000002414 leg Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000258924 Ctenocephalides felis Species 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000257159 Musca domestica Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- 241001534766 Backhousia Species 0.000 description 2
- 241000134426 Ceratopogonidae Species 0.000 description 2
- 206010066919 Epidemic polyarthritis Diseases 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 241000922049 Ixodes holocyclus Species 0.000 description 2
- 241000257226 Muscidae Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 230000009193 crawling Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241001494036 Eucalyptus olida Species 0.000 description 1
- 241001514662 Leptospermum Species 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241000378562 Melaleuca uncinata Species 0.000 description 1
- 201000005805 Murray valley encephalitis Diseases 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000710942 Ross River virus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102100036049 T-complex protein 1 subunit gamma Human genes 0.000 description 1
- 241000317854 Uncinata Species 0.000 description 1
- 208000011312 Vector Borne disease Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- QLHULAHOXSSASE-UHFFFAOYSA-N butan-2-yl 2-(2-hydroxyethyl)piperidine-1-carboxylate Chemical compound CCC(C)OC(=O)N1CCCCC1CCO QLHULAHOXSSASE-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 101150062912 cct3 gene Proteins 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- WTWBUQJHJGUZCY-UHFFFAOYSA-N cuminaldehyde Chemical compound CC(C)C1=CC=C(C=O)C=C1 WTWBUQJHJGUZCY-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940027411 picaridin Drugs 0.000 description 1
- 235000021178 picnic Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Botany (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
WO 2004/010783 PCTiAU2003/000945 -1- TITLE: INSECT REPELLANT TECHNICAL FIELD The invention relates to insect repellents, in particular to personal insect repellent products based on natural essential oils.
BACKGROUND ART The unpleasant and annoying effect which flies, mosquitoes and other insects can have on outdoor activities such as picnics and the like is well known. However, the effects of insect bites extend beyond being a mere annoyance.
Insects can transmit disease by contact with humans and human food. The ability of flies to transmit bacteria is well known. Of particular concern are the diseases communicated by mosquitoes. Mosquitoes drink mammalian blood from a variety of species, including humans and move from host to host. Thus, as well as causing irritating and often painful bites when they drink the blood of human hosts, mosquitoes have the ability to transmit viral particles into the human blood stream.
The most serious pathological conditions transmitted by mosquito include malaria, yellow fever, lyme disease, and in particular in Australia the Ross River virus (Epidemic Polyarthritis), Dengue fever, and Murray Valley encephalitis.
All of these conditions can be potentially serious and even life threatening, and mosquito-borne illnesses are responsible for thousands of deaths worldwide every year.
Clearly, the preferred method of preventing access to the human skin by mosquitoes and other insects is the use of physical barriers such as heavy clothing, nets, fly screen doors and the like.
WO 2004/010783 PCT/AU20031000945 -2- In some circumstances, it is possible to clear insects from enclosed spaces by the use of "knockdown" insecticidal compositions, insecticidal baits which attract and poison or entrap insects, or by devices such as UV lamps which attract and electrically destroy insects.
However, under circumstances where people are travelling, working, playing sport or relaxing outdoors, the use of physical barriers to avoid insect bites is impracticable and, aside from continual swatting and the like, the main means of repelling insects is to use personal insect repellent compositions. To obtain maximum effect, these compositions are generally applied directly to the skin.
The most commonly used active in personal insecticide compositions is N,Ndiethyl-m-toluamide (DEET). DEET has been used for around 50 years and is regarded as the industry standard in personal insect repellents. DEET is usually used in personal repellent products at compositions of around 15-20 wt% of the total mixture. DEET is highly effective and has a long retention time on the skin.
DEET however suffers from some disadvantages in that it is known to be aggressive to plastics and under some circumstances can cause irritation of the skin, and even more particularly, the eyes and mucus membranes. DEET also leaves a somewhat sticky, greasy feel on the skin.
In recent years, there have been toxicity concerns raised in relation to the use of
DEET.
Some efforts have been expended to find alternatives to DEET. One of these alternatives is picaridin, which has been shown to be efficacious in repelling insects.
However, because it is a synthetic compound it may be perceived by some sectors of 00 -3- 0 O the community as being less desirable than those compounds based on natural materials.
t Natural materials such as unrefined essential oils have been used from time to time as insect repellents. The most common among these are, for example citronella and limonene. However, essential oils are known in the art to provide generally low levels of insect repellency and, more importantly, because they are highly volatile, are known to 0be unsuitable because of their lack of long-term efficacy, especially where they are 00
(N
Mc, spread thinly on warm human skin and exposed to the elements, where rapid evaporation would be expected.
Even as recently as July 2002, it was reported Eng. J. Med., Vol. 347, No. 1, p. 13) that currently available non-DEET repellents (including, inter alia, a number of essential oils) do not provide protection for durations similar to those of DEET-based repellents and cannot be relied on to provide prolonged protection in environments where mosquito borne diseases are a substantial threat.
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of common general knowledge in the field.
Accordingly, it is object of the present application to overcome one or more of the above disadvantages or at least to provide an alternative repellent formulation to those already available.
DESCRIPTION OF THE INVENTION The present invention relates to an enduring N,N-diethyl-m-toluamide free insect repellent composition including an essential oil or a combination of two or more essential oils as an active insect repelling agent.
According to a first aspect of the invention there is provided an enduring insect repellent composition including an essential oil or a combination of two or more 00 -3a-
O
essential oils as an active insect repelling agent, and wherein the essential oil or the two Sor more essential oils are selected from the group consisting of: backhousia citriodora oil, melaleuca ericafolia oil, callitrus collumellaris (leaf) oil, callitrus glaucophyla oil, melaleuca linarifolia oil and combinations thereof.
According to a second aspect of the invention there is provided a method of 00 repelling an insect including the steps of providing to a surface a composition according 0 WO 2004/010783 PCT/AU2003/000945 -4- The compositions are especially suited to personal skin application.
By enduring, it is meant that the insect repellent is efficacious for a time compatible with N,N-diethyl-m-toluamide (DEET).
Preferably and more specifically, the enduring composition has repellency after two hours of at least 90% and more preferably at least 95% of the initial repellency at the time of application.
It is also preferable that the enduring composition has an initial efficacy of at least 90% that of DEET, and more preferably, an initial efficacy of at least 95% that of
DEET.
Preferably, the essential oil is selected from the group consisting ofbackhousia citriodora oil, melaleuca ericafolia oil, callitrus collumellaris (leaf) oil, callitrus glaucophyla oil, melaleuca linarifolia oil and combinations thereof. Most preferably the essential oil is backhousia citriodora oil or melaleuca ericafolia oil, or even more preferably, the essential oil is a mixture of backhousia citriodora oil and melaleuca ericafolia oil. If a mixture of oils is used, preferably the oils are selected on the basis of complementary activity profiles as displayed over a period of about two hours.
The essential oil or mixture of oils may be present in the repellent composition in any amount. Preferably, the essential oils alone or in combination are present in an amount of up to 20% wt/wt, or more preferably up to 10% wt/wt. If the essential oil is backhousia citriodora oil, it is preferably present in an amount of up to and more preferably around If the oil is melaleuca ericafolia oil, it is preferably present in an amount of up to and more preferably around 2-4%.
WO 2004/010783 PCT/AU2003/000945 Most preferably, the invention provides an insect repellent including a blend of melaleuca ericafolia oil and backhousia citriodora oil. The ratio of melaleuca ericafolia oil to backhousia citriodora oil is preferably between 10:1 and 1:10, and more preferably between 2:1 and 4:1.
The above preferred ratios were found to provide the best combination for the above two compounds. The individual oils have different fractions which evaporate at different rates. The melaleuca ericafolia oil, for instance, is believed to provide most of the repellency in the initial stages, while the backhousia citriodora oil provides a higher contribution to the repellency after about the first hour.
Where the embodiments of the present invention relate to the use of gels or creams, those skilled in the art will appreciate that where unstated, the percentages referred to are %wt/wt. Where the formulations are sprayable, the formulation is %wt/volume.
As mentioned above, essential oils have generally been considered to be unsuitable as insect repellents because of their inherently high volatilities and low efficacies after relatively short periods of time. Individuals are generally unwilling or unable to reapply insect repellents repeatedly after only short time intervals.
Surprisingly, in the present invention, it has been found that selected essential oils exhibit durations of action which render them commercially useful as insect repellents. Further, by combining specific essential oils, it is possible to extend the efficacy of the combination over a longer duration of action than would be expected from the individual oils alone.
WO 2004/010783 PCT/AU2003/000945 -6- Essential oils are a complex blend of organic compounds, sometimes containing up to several hundred component compounds. The oils used in the present invention typically contain around fifteen different compounds.
Essential oils contain a vast array of compounds of different structural classes including aldehydes (eg citronellal), cyclic alkenes (eg pinene, phellandrene), aromatic hydrocarbons (eg p-cymene), phenols( eg p-isopropylphcnol), aromatic aldehydes (eg cuminal) and epoxides (eg eucalyptol).
Thus, unlike a single pure compound, an essential oil may have a unique evaporation profile, with some compounds evaporating more rapidly than others.
Once exposed to skin and air, an essential oil composition does not merely evaporate like a homogenous compound, but changes in composition and efficacy as it does so.
It is possible in some cases that one or more rapidly evaporating components of the essential oil mask more efficacious, less volatile components, so in some instances, efficacy in repelling insects may actually rise at some points in the evaporation profile.
The possibility also exists of chemical changes within the oil. Some essential oil components are functionalised, for instance with carbonyl groups or hydroxyl groups, and so may be capable of reaction with the skin of the subject (normal skin is usually slightly acidic).
While individual essential oils are usually chemically stable, this does not preclude the possibility of reaction between components in two or more essential oils, and more importantly, it does not preclude the possibility of hydrogen bonding (or other types of non bonded interactions) between components, which is likely in the case of groups bearing oxygen functionalities. Such non-bonded interactions are WO 2004/010783 PCT/AU2003/000945 -7complex and lead to the oil behaving differently from the sum of its constituent parts.
When two or more oils are mixed, there exists the possibility of different types of interaction so a combination of oils may again behave differently from each of the starting oils.
Preferably, the enduring insect repellent further includes an agent adapted to enhance the insect repellency after two hours of the composition relative to the efficacy of the essential oil or oils alone. Most preferably, the enhancement is synergistic. Examples of agents adapted to enhance the insect repellency include film formers, hydrocarbons or fatty acids of hydrocarbons.
Any suitable film former may be used. Those examples of film formers which are particularly useful are those film formers used in sunscreen formulations as barriers to prevent water from deactivating the active agents. Examples of film formers include PVP; PVP/hexadecene, PVP/eicosene copolymers (such as are sold under the trade name Antaron), trimethylpentanediol/adipic acid/isononanoic acid copolymers (such as are sold under the trade name Lexorez TC8), trimethyl pentanediol/adipic acid/glycerin crosspolymers (such as are sold under the name Lexorez 200) or polycarbamyl polyglycol esters (such as are sold under the trade name Pecogel). C10-C12 fatty acids are suitable for use in the present invention.
Other film formers may include poly(vinyl pyrrolidone/1-triacontene) acrylate copolymers, acrylate/octylacrylamide copolymers, acrylate/VA copolymer, amodimethicone, AMP/acrylate copolymers, behenyl beeswax, behenyl/isostearyl, beeswax, butylated PVP, butyl ester of PVM/MA copolymers, calcium/sodium PVM/MA copolymers, dimethicone, dimethicone copolyol, dimethicone/mercaptopropyl methicone copolymer, dimethicone WO 2004/010783 PCT/AU20031000945 -8propylethylenediamine behenate, dimethicolnol ethylcellulose, ethylene/acrylic acid copolymer, ethylene/MA, copolymer, ethylene/VA copolymer, fluoro C2-8 alkyldimethicone, hexanediol beeswax, hydrogenated styrene/butadiene copolymer, hydroxyethyl ethylcellulose, isobutylene/MA copolymer, laurylmethicone copolyol, methyl methacrylate crosspolymer, methylacryloyl ethyl betaine/acrylates copolymer, microcrystalline wax, nitrocellulose, octadecene/MA copolymer, octadecene/maleic anhydride copolymer, octylacrylamide/acrylate/butylaminoethyl methacrylate copolymer, oxidized polyethylene, perfluoropolymethylisopropyl ether, polyacrylic acid, polyethylene, polymethyl methacrylate, polypropylene, polyquatemrnium- polyquaternium- 11, polyquaternium-28, polyquaternium-4, PVVM/MA decadiene crosspolymer, PVM/MA copolymer, PVP/decene copolymer, PVP/MA copolymer, PVP/VA copolymer, silica, silica dimethyl silylate, sodium acrylate/vinyl alcohol copolymer, stearoxy dimethicone, stearoxytrimethylsilane, stearyl alcohol, stearylvinyl ether/MA copolymer, styrene/DVB copolymer, styrene/MA copolymer, tetramethyl tetraphenyl trisiloxane, tricontanyl trimethyl pentaphenyl trisiloxane, trimethylsiloxysilicate, VA/crotonates copolymer, VA/crotonates/vinyl propionate copolymer, VA/butyl maleate/isobornyl acrylate copolymer, vinyl caprolactam/PVP/dimethylaminoethyl methacrylate copolymer, vinyldimethicone and the like.
The insect repellents of the present invention may be formulated in any known carrier system. Preferably, the repellents are formulated as gels, creams (two phase systems), lotions (thinned creams or aqueous alcohols) or spray on formulations (usually alcohol based). Those skilled in the art will appreciate that while some forms WO 2004/010783 PCT/AU20031000945 -9of base are preferred, a wide variety of known standard generic and proprietary carriers may be used without departing from the concept of the present invention.
Preferably, the insect repellents of the present invention are in the form of a lotion, cream or gel. In certain preferred embodiments, the gel contains PVP/eicosene copolymer.
The invention may also be in the form of a stick applicator which can be applied to the skin.
Any lotion base is suitable for the purposes of the present invention.
The gels are preferably based on avocado oil or sweet almond oil. Preferably, the gels are thickened with silica.
The bases of the present invention may also contain other ingredients and excipients, which may be physiologically inactive (such as colourants) or may have cosmetic use or otherwise act to modify the formulation property, such as waxes. The excipients may also be active agents. Examples of active agents which are particularly preferred are those which exhibit sunscreen activity.
Those skilled in the art will also appreciate that the formulations of the present invention may be formed by a variety of processes. These include hot processes (where mixing involves heating to liquefy one or more of the ingredients prior to mixing) or cold processes (where the mixing of all the ingredients is carried out without prior heating). If a hot process is used, it is preferable that the repellent oil or oil blend of the present invention is introduced after the base formulation has cooled.
If a cold process is used, the repellent oil or oil blend of the present invention may be introduced at any time.
WO 2004/010783 PCT/AU20031000945 Preferably, the composition is effective against mosquitoes, flies, sandflies, leeches, fleas and ticks. In particular, the repellent is efficacious against mosquitoes of the species Aedes aegypti.
The insect repellents may also be in the form of a spray, for example an alcohol based spray.
BEST MODES FOR CARRYING OUT THE INVENTION In Vitro Testing: General Protocol The general protocol for determining Mosquito repellency in vitro is as follows.
1) 50 Female sucrose fed mosquitoes were introduced into a screened cage measuring 45 x 30 x 30cm. The cage was fitted with a clothed sleeve to allow the introduction of an arm without escape of the mosquitoes.
2) One forearm of a volunteer was left untreated and the other forearm was treated with a candidate repellent. The forearm was sprayed from distance of 15cm to give even coverage. The amount of aerosol sprayed was noted.
3) Both hands and forearms were left to dry before being covered up with long rubber gloves. The rubber gloves had a 25cm 2 area removed to provide exposed skin at the back of the hand to the mosquitoes. No other skin was exposed to the mosquitoes in order to prevent any unwanted bites.
4) The untreated arm was placed in the cage and was exposed for a period of minutes. The number of mosquitoes landing and/or biting on the exposed skin was noted.
The treated arm was placed in the cage and was exposed for a period of minutes. The number of mosquitoes landing and/or biting on the exposed skin was noted.
WO 2004/010783 PCT/AU20031000945 -11- 6) Steps 4 to 6 were repeated at intervals of 15, 30, 45, 60 and 120 minutes after repellent application.
The above procedure was repeated on 3 or more volunteers to give total or full replications.
Percentage Repellency Of Mosquitoes At Various Times After Essential Oil Application The efficacy of various essential oils as insect repellents was investigated. The method of testing involved placing a 2g sample of a cream containing 2 10% the essential oil on to the volunteer arm from the wrist to the elbow and placing into a mosquito cage as detailed above. The results given below in the table show the percentage repellency of each oil in a cream base relative to the control which is an untreated arm.
WO 2004/010783 WO 204/00783PCT/A1J20031000945 12 TABLE 1 Percentage Mosquito Repellency v Time for a Variety of Essential Oils Time from Application (min) Essential Oil Cone 0 15 30 45 60 120 backhousia 5 86 54 25 46 24 36 citriodora callitrus 5 71 48 31 18 41 0.1 collumellaris (wood) callitrus 10 79 47 35 11 0 17 collumellaris (leaf) leptospermumn 5 89 33 13 3 0 0 liversidgeii leptospermum 5 94 38 0 .5 .6 0 petersoni callitrus 5 86 72 72 24 57 13 glaucophyla eremophilla, 10 74 42 36 0 24 2 mitchelii eucalyptus 10 92 41 21 0 0 0 polybractea eucalyptus 10 86 68 30 0 13 0 rachata melaleuca 10 94 87 61 21 50 18 linarifolia melaleuca 10 97 63 75 38 41 26 ericafolia melaleuca 10 84 67 31 44 17 11 uncinata backhousia 2 56 12 25 0 2 0 anisata WO 2004/010783 PCT/AU2003/000945 -13- Surprisingly, it was found that some of the essential oils, especially the backhousia citriodora oil and the melaleuca ericafolia oil had retained good repellency characteristics after 120 minutes. It was believed these warranted further investigation. Other essential oils, such as Callitrus collumellaris (leaf) oil, Callitms glaucophyla oil, Melaleuca linarifolia oil and Melaleuca uncinata oil were also not without promise.
EFFECT OF BASE TYPE The effect of the nature of the type of product base, ie whether the base was a cream, lotion or gel, was investigated. The percentage repellency at various times was evaluated for three different base types with four different formulations. Three of the formulations were in accordance with the present invention, being mixtures of backhousia citriodora oil and melaleuca ericafolia oil. These formulations were compared against a control formulation containing DEET.
TABLE 2 Percentage Mosquito Repellency v Time for Different Base Types Time from Application (min) BASE 15 30 45 60 120
DEET
92 79 75 72 34 in cream base 2% backhousia citriodora 8% melaleuca ericafolia 79 54 54 35 19 in cream base 2% backhousia citriodora 8% melaleuca ericafolia 64 54 61 40 32 in lotion base 2% backhousia citriodora 8% melaleuca ericafolia 73 65 52 43 27 in gel base WO 2004/010783 PCT/AU2003/000945 -14- The lotion base also contained 5% Diisopropyl Adipate as adjunct.
Surprisingly, the natural essential oils remained more efficacious in lotion and gel bases rather than in a cream base. The 2% backhousia citriodora oil and 8% melaleuca ericafolia oil in lotion base was able to maintain an efficacy similar to that of DEET in a cream base. The gel base also appeared promising.
The percentage repellency at various times after application was measured for gel and cream bases which both contained an adjuvant, and compared against a commercially available DEET containing compound. The gel and cream bases of the present invention as tested contained 1% backhousia citriodora oil, 4% melaleuca ericafolia oil, 10% diisopropyl adipate (as adjunct) and silicon dioxide (as adjunct), in the case of the gel and 3% in the case of the cream.
The commercial control contained 6.98% DEET and 2.79% Di-n- propyl isochinchomerate.
TABLE 3 Percentage Mosquito Repellency v Time for Different Base Types Time from Application (min) Base 0 15 30 45 60 120 Gel 96 60 75 64 66 Cream 83 45 81 52 37 Comparative 96 99 96 92 90 86 It can be seen from the above that while the essential oils give good initial results (even comparable to those for the DEET product) in general the degree of WO 2004/010783 PCT/AU2003/000945 repellency drops quite markedly after around 30 minutes, suggesting the active is losing efficacy.
In order to further increase the efficacy of the insect repellents, the possibility was investigated of adding various agents to attempt to retard the evaporation of the oils and therefore improve product efficacy.
One class of compounds found to be effective are film-forming agents.
Because it was also believed that short chain hydrocarbons may also inhibit oil evaporation, a C0I-C12 fatty alcohol was tested as an additive.
The following table shows the effects of adding various film forming or potential evaporation retarding agents to a 4% Melaleuca Ericafolia oil 1% Backhousia Citriodora oil combination in a cream or gel base.
WO 2004/010783 WO 204/00783PCT/A1J20031000945 -16- TABLE 4 Percentage Mosquito Repellency v Time for Different Film Former Types Time from Application (min) Formulation 0 15 30 45 60 120 2% PVP, PVP/Eicosene copolymer 90.4 87.6 71.2 69.1 59.1 26.0 Cream 2% PVP, PVP/Polycarbamyl Polyglycol 95.3 91.3 76.7 82.2 63.8 52.9 Ester Cream 2% PVP, PVP/Eicosene cpoyme 95.3 86.4 77.2 70.7 57.8 40.1 C10-C12 alcohol Cream PVP/Eicosene copolymer 99.3 96.7 97.2 90.7 84.1 74.0 Gel trimethylpentanediol/ adipic acid/isononanoic. acid copolymer. 96.4 95.5 95.8 77.9 71.5 76.9 Gel trimethylpentanediol! 98.4 96.7 98.5 85.1 71.1 75.9 adipic acid copolymer Gel WO 2004/010783 PCT/AU20031000945 -17- From the above, it can be seen that the gel bases were the best, although the second and third formulations were also significantly improved in their long-term efficacy relative to the products without film formers. Given that the film formers have no intrinsic repellency properties, this clearly demonstrates a synergistic relationship between the essential oils and the film former.
The bases were further reviewed with the aim of further extending the effective repellency lifetime.
A gel based on sweet almond oil was used. The efficacy was compared with an emulsion-based formulation containing PVP/Eicosene copolymer. An alcohol based product, containing Lexorez TC8 was also tested. The alcohol based product may be useful as a sprayable repellent.
TABLE 5 Percentage Mosquito Repellency v Time for Different Base Types Time from Application (min) 0 15 30 45 60 120 Gel Sweet Almond Oil 96.0 91.3 82.0 82.7 52.5 65.3 PVP/eicose ne copolymer Emulsion PVP/Eicose 97.7 79.4 65.7 67.4 40.2 44.6 ne copolymer Alcohol Lexorez- 97.3 82.9 77.7 72.2 44.1 41.9 TC8 WO 2004/010783 PCT/AU2003/000945 -18- These results show the gel to be most effective. While the other products are not quite as effective in the enclosed test environment, it is likely that they may still be effective in the field, given the concentration of mosquitoes in the environment is much lower. It may be possible to obtain improved results by increasing the amount of essential oils for a spray, or increasing the film forming properties.
The compositions of the present invention can also be incorporated into sunscreen formulations. The introduction of sunscreen components had no effect on the insect repellency of the mixture.
The effect of varying the ratios of Melaleuca Ericafolia oil Backhousia Citriodora oil was investigated. Changing the ratio of Melaleuca Ericafolia oil: Backhousia Citriodora oil from 4:1 to 4:2 was examined first.
TABLE 6 Percentage Mosquito Repellency v Time for Different Ratios of Essential Oils for a Sprayable Alcohol Based Product.
Time from Application (min) Active Ratio 0 15 30 45 60 90 120 4% Melaleuca Ericafolia 97.0 90.5 82.0 81.9 74.9 84.8 69.5 2% Backhousia Citriodora 4% Melaleuca Ericafolia 97.3 82.9 77.7 72.2 44.1 41.8 41.9 1% Backhousia Citriodora These results showed a significant increase in the long-term efficacy of the product. Further increasing the amount ofbackhousia citriodoria oil from 1 to 2% had little effect in non-sprayable compositions, such as gel based or lotions.
WO 2004/010783 PCT/AU20031000945 -19- IN VITRO TESTING: HOUSE FLY REPELLENCY The efficacy of the material as a house fly repellent (in addition to a mosquito repellent) was also investigated, using a similar protocol to the mosquito repellency tests.
The formulations below were identical and were in a gel base. Both contained 4% melaleuca ericafolia oil 1% backhousia citriodora oil, and 5% PVP/eicosene copolymer as film former. One formulation also contained other essential oils to determine if these would enhance efficacy. The results were also compared to those obtained earlier for mosquitoes.
TABLE 7 Percentage Repellency for House Flies v Time and Comparison with Mosquito Results Time after Application (minutes) Base 0 15 30 45 60 120 House Flies gel 92.6 95.3 96.7 97.1 92.8 77.4 gel 98.5 97.6 98.9 97.1 92.3 73.0 callitrus collumellaris +2%Eucalyptus olida Mosquitoes gel 99.3 96.7 97.2 90.7 84.1 74.0 These results show that the formulation of the present invention is particularly effective as a fly repellent as well as a mosquito repellent. Further, it appears to suggest, in the case of the second house fly repellent, that increasing the amount of essential oils seemed not to change the efficacy of the mixture.
WO 2004/010783 PCT/AU2003/000945 IN VITRO TESTING: FLEAS, TICKS AND LEECHES Each form of repellent was also tested against fleas, ticks and leeches. The gel and emulsion each contained Backhousia citriodora oil at 1% and Melaleuca ericafolia oil at with PVP/Eicosene Copolymer film former at 4% in the gel and 5% in the emulsion. The spray contained 2% Backhousia citriodora oil and 4% Melaleuca ericafolia oil with Trimethylpentanediol/Adipic acid/Isononanoic acid copolymer film former at The commercially available DEET containing spray used for comparison was "Off! Skintastic" TM(S.C. Johnson) which contained 6.98% DEET and 2.79% Di-npropyl isocinchomeronate.
Note in these experiments, the application rate of the gel was half that of the other forms of repellent.
The efficacy of the products against the Cat Flea (Ctenocephalidesfelis) was evaluated in-vitro according to the following protocol: 1) 30 Cat Fleas were held in a tall glass beaker with a filter paper on the bottom.
2) A volunteer placed an exposed finger treated with 4 mg/cm 2 emulsion or spray repellent (2mg/cm 2 in the case of the gel repellent) inside the beaker.
3) The number of fleas jumping up to, and remaining on the finger was recorded.
4) The test was repeated with a new batch of fleas at each time point as it was observed that the products were having a knockdown effect on the fleas.
An untreated finger was used as a control.
WO 2004/010783 PCT/AU2003/000945 -21- 6) The above procedure was repeated on 5 volunteers to give total or full replications.
TABLE 8 Percentage Repellency for Cat Fleas v Time compared to a commercially available DEET product Time from Application (min) 0 30 60 90 120 Gel 94.6 64.9 50.8 15.1 13.7 Emulsion 100.0 87.4 78.0 73.1 47.6 Spray 99.1 91.9 84.7 77.3 35.5 Commercial DEET 96.4 90.1 74.6 73.1 45.2 Containing Spray These results indicate that the performance of the spray and emulsion compares favourably to that of the DEET containing product. While the gel's repellency appears lower in the test environment, its performance in the field may be greater due to the reduced concentration of insects in the outdoor environment.
The efficacy of the product against the Dog Paralysis Tick (loxides holocyclus) was evaluated in-vitro according to the following protocol: 1) A volunteer's hand was treated with 360 mg of emulsion or spray repellent (180mg in the case of the gel repellent).
2) The hand was then placed into a dish containing 10 ticks.
WO 2004/010783 PCTiAU2003/000945 -22- 3) The number of ticks crawling onto the hand after 5 seconds was then recorded.
4) An untreated hand was used as a control.
The above procedure was repeated on 5 volunteers, at 30 minute intervals, to give total or full replications.
TABLE 9 Percentage Repellency for Dog Paralysis Ticks v Time compared to a commercially available DEET product Time from Application (min) 60 90 120 Gel 80.8 60.7 73.3 57.7 Emulsion 100.0 71.4 83.3 65.4 Spray 84.6 75.0 60.0 57.7 Commercial DEET 73.1 85.7 80.0 80.0 Containing Spray These results indicate that all products are quite effective as tick repellents. It is quite likely repellency results will be even higher in the outdoor environment.
The efficacy of the products against the Leech of genus microbdella sp. was evaluated in-vitro according to the following protocol: 1) A volunteer's hand was treated with 4mg/cm 2 of emulsion or spray repellent (2mg/cm 2 in the case of the gel repellent).
WO 2004/010783 PCT/AU2003/000945 -23- 2) The hand was then placed into a dish containing 10 leeches.
3) The number of leeches crawling onto the hand and remaining there after approximately 5 seconds was recorded.
4) An untreated hand was used as a control.
5) The above procedure was repeated on 5 volunteers, at 30 minute intervals, to give total or full replications.
TABLE 10 Percentage Repellency for Leeches v Time compared to a commercially available DEET product Time from Application (min) 60 90 120 Gel 97.9 67.4 48.9 27.7 Emulsion 100.0 100.0 93.6 80.9 Spray 97.9 97.8 95.7 63.8 Commercial 100.0 84.8 87.2 89.4 These results indicate that the emulsion and spray products are quite effective as leech repellents. The gel appears to have good initial repellency which tends to diminish over time. While leech concentrations in the environment may be lower, other factors such as the dampness of the environment in which they live may influence results that would be obtained in the field.
WO 2004/010783 PCT/AU2003/000945 -24- In Vivo Testing: Bush Fly Repellency A field study was carried out to compare the repellency of various insect repellents against the bush fly. The test was conducted under confidential conditions on private property in South West Queensland, where the predominant flying insect species was the bush fly (Musca Vetustissima). The test was conducted from early morning to mid afternoon in early sumner, over a six-hour period. The number of insects landing was assessed at various nominated times during this period. In particular, prior to repellent application and at 15, 30, 45, 60, 90, 120, 180, 240 and 360 minutes post insect repellent application.
Volunteers selected for the study were males and females between the ages of 18 and 65 years. All volunteers wore shorts to expose the lower leg below the knee.
Following repellent application and between assessments volunteers were free to walk, stand or sit. The temperature was warm to hot, around 30°C, leading to volunteers sweating for much of the study period. The volunteers also walked around the property in between assessments resulting in the repellent being subjected to long grass and direct sunshine.
The repellent gel contained 4% melaleuca ericafolia oil and 1% backhousia citriodora oil and was applied at a rate of 1.8 grams per lower leg. The repellent emulsion also contained 4% melaleuca ericafolia oil and 1% backhousia citriodora oil and was applied at a rate of 3.6 grams per lower leg. The repellent spray contained 4% melaleuca ericafolia oil and 2% backhousia citriodora oil and was applied at a rate of 3.6 grams per lower leg and the commercial DEET containing formulation SC Johnson "Off Skintastic"TM Spray was applied at a rate of 3.6 grams per lower leg.
WO 2004/010783 PCT/AU20031000945 Each treatment was replicated with 5 volunteers, as well as a control group of a similar size.
Each of the volunteer's legs were marked just below the knee and just above the ankle to mark the area for repellent application. The repellent was applied at the requisite rate per lower leg. To prevent contamination of the repellent of other subjects, the applicators wore disposable surgical gloves. One repellent was applied to one leg of each volunteer and one repellent was applied to the other. The repellents were allocated relatively evenly to either the right or left leg.
Before repellent application at the start of each new day of testing, a check was made that there was sufficient insect population pressure by confirming that insects landed on both untreated legs of all subjects. This also checked the inherent repellency of the test subjects to bush flies.
The limbs were exposed to bush flies for a period of 6 hours and assessed at the times as set above. A variety of base types as optimised above was used. A comparative test using a commercially available sample was also used. The landing number of flies over a ten minute period at the various times for a period greater than one second during the test duration were counted. Landings were defined as resting on the limb and not merely touching it. After the flies had settled they were disturbed by moving the limb. The above was repeated four times to complete five replicates for each formulation.
WO 2004/010783 PCT/AU2003/000945 -26- Percentage Repellency of Bush Flies at Various Times After TABLE 11 Application Time from Application (min) 30 45 60 90 120 180 240 360 Gel 93.9 96.7 96.2 95.8 98.0 97.6 92.1 83.7 77.5 Emulsion 93.9 100 97.7 99.3 98.5 97.6 93.6 69.2 75.3 Spray 100 100 98.5 100 99.5 98.2 93.6 88.5 78.7 Commercial 94.4 93.3 95.5 93.7 96.0 94.6 91.6 90.4 91.0
DEET
Containing Spray The results appear above. The percentage repellency helps correct for any change in insect pressure during the course of the study. The percentage repellency is calculated using the following formula: Repellen= No. Landings untreated limb No. Landings on treated limb X 100 Repellency x 100 No landings on untreated limb Statistical Analysis The difference between treatment means in the number of bush fly landings was assessed for significance using analysis of variance (Inova, SPSS version 1999). Only data obtained 180 minutes and 360 minutes after the start of the trial were analysed. Data was checked for compliance with assumption of normality and variance homogeneity. Data for assessment at 180 minutes after the start of the experiments were ln(x 1) transformed to meet later assumptions while data for WO 2004/010783 PCT/AU2003/000945 -27assessment at 360 minutes after the start of the trial better approached assumptions without any transformation.
The analysis shows that there were significant differences between treatments for both 180 minute and 360-minute assessment times. F 420 10.66, P<0.0001 and
F
4 2 0 14.713, P<0.0001 respectively. The analysis also show that there were significant differences between all active treatments and the control at both 180 minutes and 360 minutes post repellent application. Pairwise comparison between repellent treatments and untreated control was calculated and assessed using Dunn- Sidak adjusted probabilities (the nominal probability of 5% was adjusted to 1.274 for four comparisons).
Table 12 shows a summary of the statistical analysis. The significance of differences between treatments was determined using the pairwise comparison control vs repellents. Dunn-Sidak adjusted probability was used.
TABLE 12 Statistical Analysis of Bush Fly Results Treatment Mean SD Significance Mean SD Significance Number Number Landings Landings after 3 h after 6 h Gel 2.20 2.68 S 4.00 2.12 S Emulsion 1.80 3.03 S 4.40 4.39 S Spray 1.80 2.17 S 3.80 4.82 S Commercial 1.80 2.05 S 1.60 2.30 S
DEET
Containing Spray Control 28.80 8.80 17.80 4.44 WO 2004/010783 PCT/AU20031000945 -28- S= significant at adjusted probability of 1.274% It can be seen that the bush fly is attracted to skin, particularly after sweating.
Without a repellent present, the bush fly will land on the skin and wander over the surface searching for secretions such as sweat, tears and saliva. Favourite sites include the face and the back although exposed limbs are also very attractive. When a suitable repellent is present the bush fly will come close to the skin and will then veer off or touch the skin for a fraction of a second before flying off. Each of the active treatments had a statistically significantly lower number of landings by bush flies than the control at both 180 minutes and 360 minutes after application. Control bush fly landings range from 13-74 landings in a ten-minute period on an untreated leg over the course of the study.
In a similar manner to bush flies, the efficacy of the formulations of the present invention were tested in vivo against Mosquitoes. The results in the following table show excellent efficacy for all formulations after two hours, which are comparable with DEET.
TABLE 13 Percentage Repellency of Mosquitoes in vivo at Various Times After Application Time from Application (min) 30 45 60 90 120 180 240 360 Gel 100 100 99.6 100 99.6 98.1 91.3 88.1 79.8 Emulsion 100 100 100 99.5 100 100 98.7 95.8 83.3 Spray 100 100 100 100 99.6 97.6 93.9 89.8 72.5 Commercial 100 100 100 100 100 100 99.4 98.7 94.4
DEET
Containing Spray WO 2004/010783 PCT/AU2003/000945 -29- The efficacy of the present invention against biting midges (sandflies) was also tested in a similar way. The formulations were as optimised previously, and were compared against a commercial product. Again, the Gel and Emulsion fared very well.
TABLE 14 Percentage Repellency for Biting Midges v Time Time after Application (minutes) 30 45 60 90 120 180 240 360 Gel 99 99.5 99.6 98.8 99.5 99.0 95.0 93.0 96.0 Emulsion 98.3 100 100 99.6 98.5 99.0 95.7 94.6 86.0 Spray 99.5 99.5 99.6 97.2 95.5 90.5 80.6 72.1 72.0 Commercial 100 100 100 100 100 99.5 97.1 93.8 87.0
DEET
formulation EXAMPLE FORMULATIONS As mentioned above, the present invention may be used in may different bases.
Examples of commercially useful bases are provided herewith for spray on use, emulsion use and as a formulation for use as a combination insect repellent/sunscreen.
SPRAY ON FORMULATION (I) Raw material Amount %wt/vol Ethanol 95% PG F2 68.8 Lexorez TC8 Diisopropyl Adipate 20.0 Backhousia citriodora Melaleuca ericafolia Mixed tocopherols 0.2 WO 2004/010783 WO 204/00783PCT/A1J20031000945 30 EMUJLSION BASED FORMULATIONS (1II) and (lIII Raw material Amount %Ywt/wt Amount %/wt/wt Purified water 63.05 62.55 Veegum Ultra 0.50 0.50 Xanthan Gum 0.20 0.20 Disodium. EDTA 0.05 0.05 Diisopropyl adipate 20.00 20.00 PYP! hexadecene, copolymer 5.00 PVP/eicosene copolymer 5.00 Polysorbate 60 1.50 Cocoamido propyl. betaine, 3.00 Castor Oil 1.00 Glyceryl Mono stearate A/S -3.00 Cetostearyl, Alcohol -1.00 Backliousia citriodora 2.00 2.00 Melaleuca ericafolia 4.00 4.00 Benzyl alcohol 0.50 0.50 Mixed tocopherols .020 0.20 WO 2004/010783 PCT/AU2003/000945 -31 SUNSCREEN/INSECT REPELLENT FORMULATIONS (IV) AND (V) Raw Material Amount %wt/wt Amount %wtlwt Sweet Almond Oil 55.8 54.8 PVP/Eicosene Copolymer 4.0 Diisopropyl Adipate 10.0 10.0 Orange wax 2.0 Stearic Acid 2.0 Zinc Oxide (70% in CCTG) 3.0 Titanium Dioxide M160 5.0 Talc (Coated with 1% 5.0 Chitin) Sunspheres 5.0 Mixed Tocopherols 0.2 0.2 Backhousia citriodora 1.0 Melaleuca Ericafolia 4.0 Silicon dioxide 3.0 Aniseed Oil Those skilled in the art will appreciate that compositions according to the present invention may be varied beyond those given by way of exemplification and that it may be possible to formulate other compositions in other concentrations and with other additives without departing from the inventive concept herein disclosed.
Claims (19)
1. An enduring insect repellent composition including an essential oil or a combination of two or more essential oils as an active insect repelling agent, and wherein the essential oil or the two or more essential oils are selected from the group consisting of: backhousia citriodora oil, melaleuca ericafolia oil, callitrus collumellaris S(leaf) oil, callitrus glaucophyla oil, melaleuca linarifolia oil and combinations thereof.
2. A composition according to claim 1 which is free from N,N-diethyl-m-toluamide (DEET).
3. A composition according to claim 1 or claim 2 wherein the essential oil is backhousia citriodora oil or melaleuca ericafolia oil.
4. A composition according to any one of the preceding claims wherein the essential oil is a mixture of backhousia citriodora oil and melaleuca ericafolia oil. A composition according to any one of the preceding claims wherein the essential oils alone or in combination are present in an amount of up to 20 wt%.
6. A composition according to any one of the preceding claims including backhousia citriodora oil in an amount of up to 4 wt%.
7. A composition according to any one of the preceding claims including melaleuca ericafolia oil in an amount of up to 8 wt%.
8. A composition according to any one of the preceding claims including melaleuca ericafolia oil and backhousia citriodora oil. 00 -33- O
9. A composition according to claim 8 including melaleuca ericafolia oil and c backhousia citriodora oil in a ratio between 10:1 and 1:10. A composition according to any one of the preceding claims in the form of a gel, a cream, a spray or a stick applicator.
11. A composition according to any one of the preceding claims further including an 00 MC< agent adapted to enhance insect repellency after two hours, wherein said agent is selected from the group consisting of film formers, hydrocarbons, or fatty acids of hydrocarbons, and wherein said film formers are selected from the group consisting of PVP, PVP/hexadecene, PVP/eicosene copolymers, trimethylpentanediol/adipic acid/isononanoic acid copolymers, trimethylpentanediol/adipic acid/glycerincrosspolymers, polycarbamyl polyglycol esters and C10-C12 fatty acids.
12. A composition according to claim 11 wherein the film former is effective as a barrier to prevent water from deactivating the essential oil or oils.
13. A composition according to any one of the preceding claims further including a film former selected from the group consisting of poly(vinyl pyrrolidone/1-triacontene) acrylate copolymers, acrylate/octylacrylamide copolymers, acrylate/VA copolymer, amodimethicone, AMP/acrylate copolymers, behenyl beeswax, behenyl/isostearyl, beeswax, butylated PVP, butyl ester of PVM/MA copolymers, calcium/sodium PVM/MA copolymers, dimethicone, dimethicone copolyol, dimethicone/mercaptopropyl methicone copolymer, dimethicone propylethylenediamine behenate, dimethicolnol ethylcellulose, ethylene/acrylic acid copolymer, ethylene/MA, copolymer, ethylene/VA copolymer, fluoro C2-8 alkyldimethicone, hexanediol beeswax, hydrogenated styrene/butadiene copolymer, hydroxyethyl ethylcellulose, isobutylene/MA copolymer, 00 -34- 0 laurylmethicone copolyol, methyl methacrylate crosspolymer, methylacryloyl ethyl betaine/acrylates copolymer, microcrystalline wax, nitrocellulose, octadecene/MA copolymer, octadecene/maleic anhydride copolymer, octylacrylamide/acrylatelbutylaminoethyl methacrylate copolymer, oxidized polyethylene, perfluoropolymethylisopropyl ether, polyacrylic acid, polyethylene, polymethyl methacrylate, polypropylene, polyquatemrnium-10, polyquatemium-1 1, polyquatemium-28, polyquatemium-4, PVM/MA decadiene crosspolymer, PVM/MA C1 copolymer, PVP/decene copolymer, PVP/MA copolymer, PVPVA copolymer, silica, silica dimethyl silylate, sodium acrylate/vinyl alcohol copolymer, stearoxy dimethicone, stearoxytrimethylsilane, stearyl alcohol, stearylvinyl ether/MA copolymer, styrene/DVB copolymer, styrene/MA copolymer, tetramethyl tetraphenyl trisiloxane, tricontanyl trimethyl pentaphenyl trisiloxane, trimethylsiloxysilicate, VA/crotonates copolymer, VA/crotonates/vinyl propionate copolymer, VA/butyl maleate/isobomrnyl acrylate copolymer, vinylcaprolactam/PVP/dimethylaminoethyl methacrylate copolymer, vinyldimethicone and mixtures thereof
14. A composition according to claim 10 when formulated as a gel containing 5% PVP eicosene copolymer. A composition according to any one of the preceding claims based on avocado oil or sweet almond oil.
16. A composition according to any one of the preceding claims further including one or more agents selected from the group consisting of a thickening agent, colorant.
17. A composition according to any one of the preceding claims further including a sunscreen agent. 00
18. A method of repelling an insect including the steps of providing to a surface a t composition according to any one of the preceding claims.
19. A method according to claim 18 wherein the surface is a human skin surface. A method according to claim 18 or claim 19 wherein the insects are selected from the group consisting of mosquitoes, flies, sandflies, leeches, fleas, ticks and 00 (N Mc, combinations thereof.
21. A method according to the preceding claim wherein the insect is a mosquito of the species aedes aegypti.
22. An enduring insect repellent composition substantially as herein described with reference to any one of the embodiments of the invention illustrated in the accompanying examples but excluding comparative examples.
23. A method of repelling an insect substantially as herein described with reference to any one of the embodiments of the invention illustrated in the accompanying examples but excluding comparative examples.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003281745A AU2003281745B2 (en) | 2002-07-29 | 2003-07-25 | Insect repellant |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002950436 | 2002-07-29 | ||
| AU2002950436A AU2002950436A0 (en) | 2002-07-29 | 2002-07-29 | Insect repellant |
| AU2003281745A AU2003281745B2 (en) | 2002-07-29 | 2003-07-25 | Insect repellant |
| PCT/AU2003/000945 WO2004010783A1 (en) | 2002-07-29 | 2003-07-25 | Insect repellant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003281745A1 AU2003281745A1 (en) | 2004-02-16 |
| AU2003281745B2 true AU2003281745B2 (en) | 2008-04-03 |
Family
ID=34275399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003281745A Expired AU2003281745B2 (en) | 2002-07-29 | 2003-07-25 | Insect repellant |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2003281745B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3105912B1 (en) * | 2020-01-08 | 2022-11-25 | Univ Limoges | REPELLENT COMPOSITION AGAINST SHEEP ECTOPARASITES AND METHOD FOR MAKING THIS COMPOSITION |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996028032A1 (en) * | 1995-03-14 | 1996-09-19 | Currumbin Chemicals Sales Pty. Limited | Disinfectant/insecticide composition containing eucalyptus oil and australian tea tree oil |
| US5738863A (en) * | 1994-04-12 | 1998-04-14 | Sackin; Bradley M. | Honey bee repellent composition comprising tea tree oil |
| US5965137A (en) * | 1998-11-16 | 1999-10-12 | Advanced Medical Instruments | Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases |
-
2003
- 2003-07-25 AU AU2003281745A patent/AU2003281745B2/en not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5738863A (en) * | 1994-04-12 | 1998-04-14 | Sackin; Bradley M. | Honey bee repellent composition comprising tea tree oil |
| WO1996028032A1 (en) * | 1995-03-14 | 1996-09-19 | Currumbin Chemicals Sales Pty. Limited | Disinfectant/insecticide composition containing eucalyptus oil and australian tea tree oil |
| US5965137A (en) * | 1998-11-16 | 1999-10-12 | Advanced Medical Instruments | Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases |
Non-Patent Citations (4)
| Title |
|---|
| Barnard, D.R., Repellency of essential oils to mosquitoes (diptera: culicidae)., JOURNAL OF MEDICAL ENTOMOLOGY., (1999) vol. 36(5), 625-629 * |
| Bindra, R.L. et al., Essential oil formulations as mosquito repellents in floor cleaners., INDIAN PERFUMER., (2001) vol. 45(4), 269-273 * |
| Bindra, R.L. et al., Use of essential oils containing preparation for human protection against mosquitoes., JOURNAL OF MEDICINAL AND AROMATIC PLANT SCIENCES, (2000) vol. 22, 707-709 * |
| Singh, A.K. et al., Essential oils and isolates for controlling household insects: housefly, cockroach and mosquito., JOURNAL OF MEDICINAL AND AROMATIC PLANT SCIENCES, (2001) vol. 22/4A-23/1A, 159-166 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003281745A1 (en) | 2004-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jantan et al. | Development of environment-friendly insect repellents from the leaf oils of selected Malaysian plants | |
| US5227163A (en) | Lice-repellant compositions | |
| US5346922A (en) | Insect repellent lotions and sprays | |
| CA2295988C (en) | Natural insect and arthropod repellent | |
| WO2010061354A2 (en) | Insect-repellent formulations | |
| AU659625B2 (en) | Lice-repellant compositions | |
| Oyedele et al. | Volatility and mosquito repellency of Hemizygia welwitschii Rolfe oil and its formulations | |
| AU2008238611B2 (en) | Organic pest repellent | |
| US20060182775A1 (en) | Insect repellent | |
| WO2004010783A1 (en) | Insect repellant | |
| Tuetun et al. | Celery-based topical repellents as a potential natural alternative for personal protection against mosquitoes | |
| US7988985B2 (en) | Pest repellent compositions and methods | |
| US9326520B2 (en) | Pest repellent comprising geranylacetone | |
| ES2224386T3 (en) | COMPOSITION FOR SPRAYER AGAINST ANTS CONTAINING D-LIMONENE AND PROCEDURES FOR THEIR PREPARATION AND USE OF THE SAME. | |
| AU2003281745B2 (en) | Insect repellant | |
| EP1558087A1 (en) | Insect repellent based on a mixture of essential oils | |
| EP0524972B1 (en) | Insect repellent lotions and sprays | |
| EP2161990A1 (en) | Mosquito repellent | |
| Dewi et al. | Characteristics of mosquito-repellent lotion made from pineapple peel waste | |
| CA2111909A1 (en) | Repellent composition | |
| ALEXANDER et al. | CONTAINING DIETHYL TOLUAMIDE (DEET) AND PERMETHRIN AGAINST PHLEBOTOMINE SAND FLIES (DIPTERA: PSYCHODIDAE) | |
| AU2011203303A1 (en) | Protectant against External Parasitic Infestation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |